Latest News
NewsLatest News
TIANS assists in the digital construction of Yuanda Pharmaceutical's nuclear medicine R&D and production base project
source:TIANS
date:2024-09-27

Recently, TIANS Group successfully won the bid for the Automation Project (Phase I) of the Yuanda Pharmaceutical Nuclear Medicine R&D and Production Base Construction Project of Chengdu Shetai Medical Technology Co., Ltd. (hereinafter referred to as the "Yuanda Nuclear Medicine Project") relying on its mature technical experience, system design capabilities and advanced energy-saving concepts. TIANS is mainly responsible for the Building Management System (BMS) and Environmental Monitoring System (EMS) of the nuclear medicine workshop and macromolecule workshop, helping the customer build a digital and intelligent utility engineering management platform. It realizes efficient collaborative control of utility engineering equipment (air conditioning system, chiller system, compressed air system, steam system, etc.), ensures the compliance, stability and safety of the production environment, and at the same time conducts data management of key process parameters, improves production management and control capabilities, and guarantees the quality and safety of pharmaceutical production.

Rendering of Yuanda Nuclear Medicine Project


Yuanda Pharmaceutical is a technology-innovative and international pharmaceutical enterprise integrating pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment, cardiovascular and cerebrovascular precision interventional diagnosis and treatment technology, and biotechnology. In recent years, Yuanda Pharmaceutical has looked at the global market, continuously accelerated the development process of nuclear medicine research varieties and future self-developed products, promoted the smooth domestic landing and transformation of the world's exclusive anti-liver cancer radiotherapy variety "SIR-Spheres® Yttrium [90Y] Microsphere Injection" and many innovative RDC products with high technical barriers such as TLX591, bringing new hope to the majority of patients.


Rendering of Yuanda Pharmaceutical Project


The Automation and Informatization Division of TIANS Group is deeply engaged in industry Know-How, proficient in the core technologies of major production processes and production auxiliary processes, and can closely integrate automation and informatization technologies with production processes, providing one-stop services from system design, integration and development, engineering implementation to commissioning and verification. It has provided cutting-edge factory digitalization and informatization services for many top 100 pharmaceutical enterprises. Facing the more green and lean needs of future factories, TIANS will continue to improve itself, empower customers with cutting-edge technical strength, and create the future together.